Analysis of tumor growth in mice by ultrasound imaging of the lungs indicated a significant reduction in LLC growth between the 3rd and 6th week of treatment with either the PERK inhibitor GSK2606414 or ISRIB compared to mice treated with vehicle control (Fig. 6c). Here, EIF2AK3 is linked to neoplasm.